Analysis of myelodysplastic syndromes with complex karyotypes by high‐resolution comparative genomic hybridization and subtelomeric CGH array
- 20 December 2004
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 42 (3) , 287-298
- https://doi.org/10.1002/gcc.20154
Abstract
Molecular cytogenetic techniques enabled us to clarify numerical and structural alterations previously detected by conventional cytogenetic techniques in 37 patients who had myelodysplastic syndromes with complex karyotypes. Using high‐resolution comparative genomic hybridization (HR‐CGH), we found the most recurrent alterations to be deletion of 5q (70%), 18q (35%), 7q (32%), 11q (30%), and 20q (24%), gain of 11q (35%) and 8q (24%), and trisomy of chromosome 8 (19%). Furthermore, in 35% of the patients, 20 amplifications were identified. These amplifications were shown by FISH to involve some genes previously described as amplified in hematological malignancies, such as ERBB2, MLL, and RUNX1. In addition, two other genes, BCL6 and BCL2, which are classically related to apoptosis and non‐Hodgkin lymphoma, were shown for the first time to be involved in amplification. Genomic alterations involving different subtelomeric regions with losses in 4p16, 5p15.3, 6q27, 18p11.3, and 18q23 and gains in 1p36.3 and 19p13.3 were detected by HR‐CGH. Array CGH analysis of the subtelomeric regions in some samples was able to confirm a number of these alterations and found some additional alterations not detected by conventional CGH. ©2004 Wiley‐Liss, Inc.Keywords
Funding Information
- Spanish Ministry of Science and Technology (SAF-01-0056)
- Red Temática de Centros del Cáncer, Spanish Ministry of Health (CO-010)
- Instituto de Salud Carlos III
This publication has 25 references indexed in Scilit:
- Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotypingCancer Genetics and Cytogenetics, 2004
- Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignanciesBlood, 2004
- DNA microarrays for comparative genomic hybridization based on DOP‐PCR amplification of BAC and PAC clonesGenes, Chromosomes and Cancer, 2003
- De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19Genes, Chromosomes and Cancer, 2003
- Inhibition of apoptosis in human breast cancer cells: Role in tumor progression to the metastatic stateInternational Journal of Cancer, 2002
- Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: A detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24‐color FISHGenes, Chromosomes and Cancer, 2002
- Detection of BCL2 Rearrangements in Follicular LymphomaThe American Journal of Pathology, 2002
- The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: Implications for a role of BCL6 in the down-regulation of apoptosisProceedings of the National Academy of Sciences, 2002
- Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22qGenes, Chromosomes and Cancer, 2002
- THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIASAnnual Review of Genetics, 1998